Search research articles
Contact Us
Filters
Showing results (191-200 of 217) with videos related to
Page
of 22
Sort By:
Annals of Surgical Oncology
|
August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Alice C Wei, Fang-Shu Ou, Qian Shi, et al.
Plos One
|
December 17, 2011
MicroRNA expression characterizes oligometastasis(es)
Yves A Lussier, H Rosie Xing, Joseph K Salama, et al.
JAMA Cardiology
|
May 3, 2023
Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program
Jason L Vassy, Daniel C Posner, Yuk-Lam Ho, et al.
Plos One
|
May 25, 2022
Genome-wide and phenome-wide analysis of ideal cardiovascular health in the VA Million Veteran Program
Rose D L Huang, Xuan-Mai T Nguyen, Gina M Peloso, et al.
American Journal of Epidemiology
|
June 24, 2021
Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans
Hanna Gerlovin, Daniel C Posner, Yuk-Lam Ho, et al.
Nature Communications
|
May 6, 2018
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Sean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Nature Communications
|
November 15, 2018
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Sean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Annals of Surgery
|
March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel
Natalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery
|
October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel
Matthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Cancer Discovery
|
November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 217) with videos related to
Sort By:
Page
of 22
Annals of Surgical Oncology
|
August 17, 2019
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Alice C Wei, Fang-Shu Ou, Qian Shi, et al.
Plos One
|
December 17, 2011
MicroRNA expression characterizes oligometastasis(es)
Yves A Lussier, H Rosie Xing, Joseph K Salama, et al.
JAMA Cardiology
|
May 3, 2023
Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program
Jason L Vassy, Daniel C Posner, Yuk-Lam Ho, et al.
Plos One
|
May 25, 2022
Genome-wide and phenome-wide analysis of ideal cardiovascular health in the VA Million Veteran Program
Rose D L Huang, Xuan-Mai T Nguyen, Gina M Peloso, et al.
American Journal of Epidemiology
|
June 24, 2021
Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans
Hanna Gerlovin, Daniel C Posner, Yuk-Lam Ho, et al.
Nature Communications
|
May 6, 2018
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Sean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Nature Communications
|
November 15, 2018
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Sean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Annals of Surgery
|
March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel
Natalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery
|
October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel
Matthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Cancer Discovery
|
November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
Page
of 22